TESTOSTERONE AND DIABETES: RESEARCH EXPERIENCE AND RELATED CLINICAL FINDINGS

Description

Dr. Kelly speaks about the relation between cardiovascular disease, type 2 diabetes, obesity and testosterone. He presents the hypogonadal-obesity-adipocytokine hypothesis and studies that have investigated whether testosterone therapy can break the vicious circle of low testosterone causing and being caused by these metabolic diseases.

 


 

Speakers

Dr Daniel Kelly

Dr Daniel Kelly

Sheffield University

Dr Daniel Kelly

Sheffield University

 

TESTOSTERONE THERAPY IN MEN WITH DIABETES

SANDEEP DHINDSA, M.D. - INTERVIEW

Professor of Medicine Chief, Divison of Endocrinology, Diabetes and Metabolism Saint Louis Unversity School of Medicine, USA
View now

Safety With Testosterone Theraphy

Mohit Khera, M.D., M.B.A., M.P.H. - Interview

Professor of Urology Scoot Department of Urology Baylor College of Medicine Houston, TX
View now

Practical Management of Testosterone Deficiency: The Primary Care Perspective

Dr Jonny Coxon BM BCh MA MD MRCS MRCGP FECSM - Interview

Speciality Doctor: Urology & Gender Identity Brighton, UK
View now

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Dr Andrea Isidori - Interview

Rome, Italy
View now